Developer docs
API playgroundTry for free, no card

Search company profiles

Pierre Fabre (Suisse)

Full company profile

uuid0053tgu

Namestring
Pierre Fabre (Suisse)
Legal namestring
Laboratoires Pierre Fabre
Websiteurl
pierre-fabre.ch
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Pierre Fabre (Suisse) is the Swiss regional presence of Laboratoires Pierre Fabre, a privately held French pharmaceutical and dermo-cosmetic group headquartered in Castres, France. The group operates two main divisions: Pierre Fabre Dermo-Cosmétique & Personal Care, which sells skincare, haircare, and oral care brands (Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium, Naturactive) through pharmacies and retail channels; and Pierre Fabre Medical Care, which markets prescription and OTC pharmaceuticals in oncology, gynecological diseases, and everyday health. Core technical competencies are plant-based expertise, eco-extraction, and the encapsulation and vectorization of active ingredients and pigments, supported by a 420-person R&D organization with innovation centers in Toulouse, Shanghai, and Rio de Janeiro. The group serves patients and consumers across 43 countries with a sales-led model combining country-specific websites, pharmacy distribution, and a dedicated professional ordering system for healthcare professionals.

Short descriptiontext

Laboratoires Pierre Fabre is a privately held French pharmaceutical and dermo-cosmetic group selling prescription drugs in oncology and gynecology, and a portfolio of dermo-cosmetic brands (Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium) through pharmacies across 43 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSwitzerland (Regional Operations), Switzerland
HQ citystring
Switzerland (Regional Operations)
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermo-cosmetic products, pharmaceutical medications, skincare products, oncology treatments, hair care products
Industry2 codes
1Dermocosmetics & Medical-Grade Skincare
CodeCRABAAAFPrimaryYes
2Dermatology & Aesthetics Pharmaceuticals
CodeHLAIAAAKPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Cosmetics, Beauty Supplies, and Perfume Retailers456120
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Medicinal Chemicals & Botanical Products2833
Product category
Dermo-Cosmetics and Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Products
TypeOne Time License
Description

Prescription and over-the-counter medications primarily in oncology, gynecological diseases, and everyday health conditions

pierre-fabre.com
2Dermo-cosmetic Products
TypeOne Time License
Description

Skincare, haircare, and oral care products sold through pharmacies and retail channels under brands including Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, and Elgydium

pierre-fabre.com
3Medical Dermatology
TypeOne Time License
Description

Medical-grade dermatological products under Pierre Fabre Medical Dermatology brand

pierre-fabre.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1Eau Thermale Avène
Description

Dermo-cosmetic skincare brand based on thermal water

pierre-fabre.com
+9 more records
Core offering1 text field

Pierre Fabre is a French pharmaceutical and dermo-cosmetic group that develops, manufactures and markets prescription medications (primarily in oncology, gynecology, medical dermatology and everyday health) alongside a portfolio of dermo-cosmetic brands covering skincare, haircare and oral care. Products are sold under brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium and Naturactive, and are distributed through pharmacies, retail channels and country-specific regional websites.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Pierre Fabre is a French pharmaceutical and dermo-cosmetic group with two main divisions: Pierre Fabre Dermo-Cosmétique & Personal Care and Pierre Fabre Medical Care. The dermo-cosmetic division encompasses an international brand portfolio including Eau Thermale Avène (sensitive skin care), Ducray (hair and skin care), Klorane (botanical hair care), A-Derma (plant-based sensitive skin care), René Furterer (premium hair care), Elgydium (oral care), and Naturactive (natural health products). The pharmaceutical division includes oncology innovations, medical dermatology, and treatments for gynecological diseases and everyday ailments. Research priorities span sun protection, acne treatment, atopy, wound repair, and alopecia, supported by expertise in plant-based science and eco-extraction.

Product and service10 records
1Eau Thermale Avène
CategoryDermo-cosmetic skincare brand
2Ducray
CategoryDermo-cosmetic hair and skin care brand
3Klorane
CategoryDermo-cosmetic hair care brand
4A-Derma
CategoryDermo-cosmetic skincare brand
5René Furterer
CategoryDermo-cosmetic hair care brand
6Elgydium
CategoryDermo-cosmetic oral care brand
7Naturactive
CategoryNatural health and wellness brand
8Pierre Fabre Oncologie Innovation
CategoryPharmaceutical oncology division
9Pierre Fabre Medical Dermatology
CategoryMedical dermatology division
10Pierre Fabre Pharmaceutical Care
CategoryPharmaceutical care product line
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pierre Fabre maintains business development partnerships for strategic collaborations and growth initiatives

Strategic tierCoreTypeTechnology or Integration
Description

Contract Development & Manufacturing organization supporting pharmaceutical and dermo-cosmetic product development and production

3Consortium Green Impact Index
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Transparency initiative in collaboration with the Consortium Green Impact Index for environmental impact assessment and reporting

pierre-fabre.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global beauty and dermo-cosmetic leader operating La Roche-Posay and Vichy, directly comparable to Pierre Fabre's Avène and Klorane in the pharmacy-channel skincare category, but with vastly larger scale and broader portfolio.

TypeBroad incumbent
Description

Global prestige beauty group with dermatologist-aligned brands, competing with Pierre Fabre's premium skincare brands in retail and pharmacy channels across Europe and Asia.

TypeDirect peer
Description

Thermal-water-based dermo-cosmetics brand distributed in pharmacies, closely comparable to Eau Thermale Avène in formulation philosophy, channel, and target consumer segment.

TypeBroad incumbent
Description

Consumer health and personal care company with oral care and dermo-cosmetic adjacencies (e.g., WaterPik, Nair), a partial comparable to Pierre Fabre's Elgydium oral care and personal care lines.

TypeDirect peer
Description

Pure-play dermatology and dermo-cosmetics company combining prescription and OTC skincare, directly comparable to Pierre Fabre's Medical Dermatology and Dermo-Cosmétique divisions in therapeutic and aesthetic dermatology.

TypeBroad incumbent
Description

French pharmaceutical company active in oncology and consumer health, offering comparable pharmaceutical scale and therapeutic area overlap with Pierre Fabre's Medical Care division.

TypeBroad incumbent
Description

German personal care company behind Eucerin and Nivea, with a dermo-cosmetic franchise (Eucerin) that competes directly with Avène and A-Derma across European pharmacy channels.

TypeBroad incumbent
Description

Diversified pharma and consumer health company with derma brands and women's health portfolio, partially comparable to Pierre Fabre's Pharmaceutical Care and everyday health product lines.

TypeEmerging player
Description

Dermo-cosmetic company with strong photoprotection and skincare franchises in Europe and Latin America, comparable to Pierre Fabre's sun protection and dermatology positioning.

TypeDirect peer
Description

The parent group's medical dermatology division serves as the natural internal benchmark for the dermo-cosmetic and prescription dermatology franchise overlap with specialty dermatology peers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pierre Fabre (Suisse)

Dermo-Cosmetics and Pharmaceuticalspierre-fabre.ch

Laboratoires Pierre Fabre is a privately held French pharmaceutical and dermo-cosmetic group selling prescription drugs in oncology and gynecology, and a portfolio of dermo-cosmetic brands (Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium) through pharmacies across 43 countries.

What Pierre Fabre (Suisse) does

Pierre Fabre (Suisse) is the Swiss regional presence of Laboratoires Pierre Fabre, a privately held French pharmaceutical and dermo-cosmetic group headquartered in Castres, France. The group operates two main divisions: Pierre Fabre Dermo-Cosmétique & Personal Care, which sells skincare, haircare, and oral care brands (Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium, Naturactive) through pharmacies and retail channels; and Pierre Fabre Medical Care, which markets prescription and OTC pharmaceuticals in oncology, gynecological diseases, and everyday health. Core technical competencies are plant-based expertise, eco-extraction, and the encapsulation and vectorization of active ingredients and pigments, supported by a 420-person R&D organization with innovation centers in Toulouse, Shanghai, and Rio de Janeiro. The group serves patients and consumers across 43 countries with a sales-led model combining country-specific websites, pharmacy distribution, and a dedicated professional ordering system for healthcare professionals.

Pierre Fabre (Suisse) firmographics

Firmographics
Name
Pierre Fabre (Suisse)
Legal name
Laboratoires Pierre Fabre
Website
https://pierre-fabre.ch
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Laboratoires Pierre Fabre is a privately held French pharmaceutical and dermo-cosmetic group selling prescription drugs in oncology and gynecology, and a portfolio of dermo-cosmetic brands (Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium) through pharmacies across 43 countries.
Ownership category
akta.pro rank

Pierre Fabre (Suisse) industry classification

Industry
Product category
Dermo-Cosmetics and Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Cosmetics, Beauty Supplies, and Perfume Retailers (456120)
SIC
Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
akta.pro secondary industry
Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

  • Dermo-cosmetic products
  • Pharmaceutical medications
  • Skincare products
  • Oncology treatments
  • Hair care products

Where Pierre Fabre (Suisse) is headquartered

Location

Headquarters

HQ city
Switzerland (Regional Operations)
HQ country
Switzerland
HQ region
Europe

Offices5 records

Markets served

Pierre Fabre (Suisse) business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Pharmaceutical Products: Prescription and over-the-counter medications primarily in oncology, gynecological diseases, and everyday health conditions
  2. Dermo-cosmetic Products: Skincare, haircare, and oral care products sold through pharmacies and retail channels under brands including Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, and Elgydium
  3. Medical Dermatology: Medical-grade dermatological products under Pierre Fabre Medical Dermatology brand

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Pierre Fabre (Suisse) product offering

Product offering

Core offering

Pierre Fabre is a French pharmaceutical and dermo-cosmetic group that develops, manufactures and markets prescription medications (primarily in oncology, gynecology, medical dermatology and everyday health) alongside a portfolio of dermo-cosmetic brands covering skincare, haircare and oral care. Products are sold under brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium and Naturactive, and are distributed through pharmacies, retail channels and country-specific regional websites.

Product overview

Pierre Fabre is a French pharmaceutical and dermo-cosmetic group with two main divisions: Pierre Fabre Dermo-Cosmétique & Personal Care and Pierre Fabre Medical Care. The dermo-cosmetic division encompasses an international brand portfolio including Eau Thermale Avène (sensitive skin care), Ducray (hair and skin care), Klorane (botanical hair care), A-Derma (plant-based sensitive skin care), René Furterer (premium hair care), Elgydium (oral care), and Naturactive (natural health products). The pharmaceutical division includes oncology innovations, medical dermatology, and treatments for gynecological diseases and everyday ailments. Research priorities span sun protection, acne treatment, atopy, wound repair, and alopecia, supported by expertise in plant-based science and eco-extraction.

Differentiator

Problem solved

Functional benefit

Brands

  • Eau Thermale Avène: Dermo-cosmetic skincare brand based on thermal water
  • Ducray
  • Klorane
  • A-Derma
  • René Furterer
  • Elgydium
  • Naturactive
  • Pierre Fabre Oral Care
  • Pierre Fabre Medical Dermatology
  • Pierre Fabre Oncologie Innovation

Products and services

  • Eau Thermale Avène
  • Ducray
  • Klorane
  • A-Derma
  • René Furterer
  • Elgydium
  • Naturactive
  • Pierre Fabre Oncologie Innovation
  • Pierre Fabre Medical Dermatology
  • Pierre Fabre Pharmaceutical Care

Companies that use Pierre Fabre (Suisse)

Customer profile

Segments6 records

Ideal customer profiles3 records

Pierre Fabre (Suisse) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Pierre Fabre (Suisse) partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Business Development PartnerscoreStrategic or Co-development PartnerPierre Fabre maintains business development partnerships for strategic collaborations and growth initiatives
  • Contract Development & Manufacturing PartnerscoreTechnology or IntegrationContract Development & Manufacturing organization supporting pharmaceutical and dermo-cosmetic product development and production
  • Consortium Green Impact IndexminorStrategic or Co-development PartnerTransparency initiative in collaboration with the Consortium Green Impact Index for environmental impact assessment and reporting

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Pierre Fabre (Suisse) competitors and assessment

Company assessment

Broad incumbents

  • L'Oréal: Global beauty and dermo-cosmetic leader operating La Roche-Posay and Vichy, directly comparable to Pierre Fabre's Avène and Klorane in the pharmacy-channel skincare category, but with vastly larger scale and broader portfolio.
  • Estée Lauder Companies: Global prestige beauty group with dermatologist-aligned brands, competing with Pierre Fabre's premium skincare brands in retail and pharmacy channels across Europe and Asia.
  • Church & Dwight: Consumer health and personal care company with oral care and dermo-cosmetic adjacencies (e.g., WaterPik, Nair), a partial comparable to Pierre Fabre's Elgydium oral care and personal care lines.
  • Sanofi: French pharmaceutical company active in oncology and consumer health, offering comparable pharmaceutical scale and therapeutic area overlap with Pierre Fabre's Medical Care division.
  • Beiersdorf: German personal care company behind Eucerin and Nivea, with a dermo-cosmetic franchise (Eucerin) that competes directly with Avène and A-Derma across European pharmacy channels.
  • Bayer Consumer Health: Diversified pharma and consumer health company with derma brands and women's health portfolio, partially comparable to Pierre Fabre's Pharmaceutical Care and everyday health product lines.

Direct peers

  • Uriage (dermo-cosmetic brand, Puig group): Thermal-water-based dermo-cosmetics brand distributed in pharmacies, closely comparable to Eau Thermale Avène in formulation philosophy, channel, and target consumer segment.
  • Galderma: Pure-play dermatology and dermo-cosmetics company combining prescription and OTC skincare, directly comparable to Pierre Fabre's Medical Dermatology and Dermo-Cosmétique divisions in therapeutic and aesthetic dermatology.
  • Pierre Fabre Dermatologie (subsidiary comparison): The parent group's medical dermatology division serves as the natural internal benchmark for the dermo-cosmetic and prescription dermatology franchise overlap with specialty dermatology peers.

Emerging players

  • ISDIN: Dermo-cosmetic company with strong photoprotection and skincare franchises in Europe and Latin America, comparable to Pierre Fabre's sun protection and dermatology positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Pierre Fabre (Suisse) social profiles

Digital presence

Pierre Fabre (Suisse) compliance and trust

Trust signal

Compliance2 records

Pierre Fabre (Suisse) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pierre Fabre (Suisse) leadership team

Management profile

Number of profiles

Profiles5 records

Pierre Fabre (Suisse) subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Pierre Fabre (Suisse) funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pierre Fabre (Suisse) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pierre Fabre (Suisse)

What does Pierre Fabre (Suisse) do?

Pierre Fabre is a French pharmaceutical and dermo-cosmetic group that develops, manufactures and markets prescription medications (primarily in oncology, gynecology, medical dermatology and everyday health) alongside a portfolio of dermo-cosmetic brands covering skincare, haircare and oral care. Products are sold under brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer, Elgydium and Naturactive, and are distributed through pharmacies, retail channels and country-specific regional websites.

Is Pierre Fabre (Suisse) a public or private company?

Pierre Fabre (Suisse) is a private company. It is classified as family owned and is currently operating.

When was Pierre Fabre (Suisse) founded?

Pierre Fabre (Suisse) was founded in -1. It employs 1 to 10 people.

Where is Pierre Fabre (Suisse) based?

Pierre Fabre (Suisse) is headquartered in Switzerland (Regional Operations), Switzerland, in the Europe region.

How does Pierre Fabre (Suisse) make money?

Three revenue lines are on record. Pharmaceutical Products are the primary driver. The others are dermo-cosmetic Products and medical Dermatology.

Who are Pierre Fabre (Suisse)'s main competitors?

Broad incumbents on record are L'Oréal, Estée Lauder Companies, Church & Dwight, Sanofi, Beiersdorf and Bayer Consumer Health. Direct peers are Uriage (dermo-cosmetic brand, Puig group), Galderma and Pierre Fabre Dermatologie (subsidiary comparison). ISDIN is listed as an emerging player.

Does Pierre Fabre (Suisse) have an API?

No public API is recorded for Pierre Fabre (Suisse).

What industry is Pierre Fabre (Suisse) in?

Pierre Fabre (Suisse)'s product category is Dermo-Cosmetics and Pharmaceuticals. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsLaboratoires Pierre Fabre Appoints Nicolas Zombré as CEO of U.S. Dermocosmetics Division, Signifying Growth Strategies AheadLaboratoires Pierre Fabre announced the appointment of Nicolas Zombré as CEO of its U.S. dermocosmetics division, citing nearly 20 years of company experience and prior roles in Brazil, Chile and Spain. The company reports double-digit year-over-year growth for its Avène brand, led by a 32% sales increase in Cicalfate+ Restorative Protective Cream. No financial figures or start date were disclosed.PR NewswireLaboratoires Pierre Fabre Appoints Nicolas Zombré CEO of U.S. Dermocosmetics Business, Signaling Next Phase of GrowthLaboratoires Pierre Fabre announced on August 25, 2026 that Nicolas Zombré will become CEO of its U.S. dermocosmetics operations, overseeing brands including Avène, René Furterer and Klorane. Avène has posted double-digit year-over-year growth, with Cicalfate+ Restorative Protective Cream up 32%, and is stocked at Amazon, CVS, Target, Ulta, Walgreens and Walmart. Zombré brings nearly two decades of Pierre Fabre leadership experience.MorningstarLaboratoires Pierre Fabre Appoints Nicolas Zombré CEO of U.S. Dermocosmetics Business, Signaling Next Phase of GrowthLaboratoires Pierre Fabre appointed Nicolas Zombré as CEO of its U.S. dermocosmetics business, overseeing brands including Avène, René Furterer, and Klorane. Avène has emerged as a fast-growing brand in the U.S., with Cicalfate+ Restorative Protective Cream delivering +32% growth. The appointment signals continued investment in expanding the U.S. footprint across retail, medical, and digital channels.PR NewswireÀ l'occasion du mois de sensibilisation au cancer du sein, les Laboratoires Pierre Fabre annoncent un partenariat mondial avec la fondation Know Your LemonsLaboratoires Pierre Fabre announced a global partnership with the Know Your Lemons foundation for breast cancer awareness month in October, reflecting the company's commitment to early detection education. The Know Your Lemons foundation, founded in 2014 by Corrine Ellsworth Beaumont, uses a visual metaphor of lemons to educate about breast cancer symptoms and has reached over one billion people across more than 100 countries through its award-winning mobile app and network of volunteer educators.PR NewswireLaboratorios Pierre Fabre se comprometen en la lucha contra las enfermedades pediátricas rarasLaboratorios Pierre Fabre announced its commitment to developing innovative therapies for pediatric rare diseases, highlighting collaborations with the EspeRare Foundation and Atara Biotherapeutics. The company is supporting clinical trials for XLHED and commercializing treatments for PTLD EBV+, while also advancing care for infantile hemangiomas and ichthyosis through partnerships with medical institutions and patient associations.PR NewswireScorpion Therapeutics et les Laboratoires Pierre Fabre annoncent l'inclusion du premier patient dans l'essai clinique de phase I/II évaluant STX-721Scorpion Therapeutics and Pierre Fabre Laboratories announced the enrollment of the first patient in a Phase I/II dose-escalation clinical trial evaluating STX-721, an orally bioavailable, irreversible, and highly selective mutant-specific EGFR exon 20 insertion inhibitor, in patients with locally advanced or metastatic non-small cell lung cancer. The trial aims to characterize the safety profile of STX-721, determine the maximum tolerated dose and optimal biologically active dose for a recommended Phase II dose. This marks Scorpion's second clinical program to enter clinical development this year and is one of two EGFR programs being advanced under the partnership between Scorpion and Pierre Fabre.PR NewswireLaboratoires Pierre Fabre gibt den Start des "Pierre Fabre Fund for Innovation" bekanntLaboratoires Pierre Fabre announced the launch of the 'Pierre Fabre Fund for Innovation', an open-innovation initiative designed to support biotech companies, startups, and research labs specializing in oncology and dermatology. The fund provides financial grants and expertise exchange to projects in advanced preclinical or early clinical development stages, with a primary focus on French and European entities.GlobeNewswireLaboratoires Pierre Fabre Relies on Manhattan Associates to Increase Supply Chain CompetitivenessLaboratoires Pierre Fabre selected Manhattan Associates' SCOPE supply chain solutions to improve efficiency and competitiveness. The project is underway at its Ussel warehouse and will expand to a Muret warehouse. The company expects to enhance service and operational efficiency across its global operations.